jRCT2031250618尚未招募不适用
ROH-201 ophthalmic solution phase II clinical trial in patients with vernal keratoconjunctivitis
未提供0 个研究点目标入组 12 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
入排标准
- 年龄范围
- 6age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients for whom written informed consent was obtained from the subject or a legally authorized representative
- •Patients with vernal keratoconjunctivitis
- •6 years and older at the time of informed consent
排除标准
- •Patients who require contact lens wear
- •Patients who the principal/sub investigator has determined are not suitable to participate in this study
研究者
相似试验
尚未招募
2 期
Safety and Efficacy of ophthalmic suspension (T1695 versus Ciclosporin), in participants with moderate to severe Vernal Keratoconjunctivitis (VKC).CTRI/2026/02/0104277Laboratoires THEA120
招募中
不适用
A study to check how well the Bio-M Pathfinder rapid test identifies eye diseases in patientsCTRI/2025/11/097850NovoMol-Dx Private Limited200
招募中
4 期
A clinical study of EYECRYLâ„¢ PLUS (600) intraocular lens in patients undergoing cataract surgeryCTRI/2024/02/062688Biotech vision care pvt ltd850
尚未招募
4 期
Better corneal endothelium cell protection during cataract surgery in Type 2 Diabetes Mellitus patients using different Ophthalmic viscosurgical devicesCTRI/2025/09/094198Sankara eye hospital Guntur80
尚未招募
Unknown
Post Marketing Clinical Study to Examine the safety and performance of REPER RPR-13 Hydrophobic Intraocular lens.CTRI/2024/12/078539Rayner Surgical India Pvt Ltd formerly Surgicon Healthcare Pvt Ltd50